Basic Information
Basic information for C5orf64-209-32aa
Peptide Name C5orf64-209-32aa
Genome Position chr5:61755897-61755944,61757151-61757198[+]
Species Human
Peptide Sequence MVKHSGNCKRTDGIWEGLPSSAWHQHKGEEGR
Peptide Length 32
Unique No (C5orf64-212-32aa,C5orf64-214-32aa,C5orf64-216-32aa,C5orf64-220-32aa,C5orf64-227-32aa,C5orf64-228-32aa)
Grand Average of Hydropathicity -1.2844
Relative Molecular Mass 4177.51
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000178722;C5orf64
Transcript ID/Name ENST00000656556;C5orf64-209
Transcript Length 2362
Coding Ability 0.4069
DNA Sequence Corresponding to Peptide ATGGTGAAACACTCTGGCAACTGCAAGCGGACAGATGGGATCTGGGAGGGACTCCCATCTTCTGCATGGCATCAGCACAAGGGTGAAGAGGGAAGA
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :